Feature Channels: AIDS and HIV

Filters close
21-Apr-2024 5:05 PM EDT
Perinatal Transmission of HIV Can Lead to Cognitive Deficits
Georgetown University Medical Center

Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as children grow older, according to a detailed analysis of 35 studies conducted by Georgetown University Medical Center neuroscientists. The finding helps pinpoint the geographic regions and factors that may be important for brain development outcomes related to perinatal HIV infection: mother-to-child HIV transmission during pregnancy, labor and delivery, or breastfeeding.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Seth Himelhoch named Chair of the Department of Psychiatry and Behavioral Neuroscience at the University of Chicago
Released: 12-Apr-2024 12:05 PM EDT
Seth Himelhoch named Chair of the Department of Psychiatry and Behavioral Neuroscience at the University of Chicago
University of Chicago Medical Center

Himelhoch comes to UChicago from the University of Kentucky, where his public health research has focused on interventions for those with HIV and substance use disorders and cancer control.

Released: 11-Apr-2024 7:05 AM EDT
Study confirms how RNA chemical modifications benefit HIV-1
Ohio State University

A chemical modification in the HIV-1 RNA genome whose function has been a matter of scientific debate is now confirmed to be key to the virus’s ability to survive and thrive after infecting host cells, a new study has found.

Newswise: Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
Released: 10-Apr-2024 9:30 AM EDT
Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
Wistar Institute

Wistar's Dr. Abdel-Mohsen has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV.

Not for public release

This news release is embargoed until 8-Apr-2024 5:00 PM EDT Released to reporters: 2-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 8-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 27-Mar-2024 10:05 AM EDT
Wake Forest University School of Medicine, Advocate Health and Vysnova Partners Awarded $3.4 Million Contract by CDC to Lead Large-Scale Sexually Transmitted Infection Research Project
Wake Forest University School of Medicine

Wake Forest University School of Medicine, Advocate Health and Vysnova Partners have been awarded a $3.4 million, four-year contract to study HIV, Mpox and other sexually transmitted infections (STIs).

Released: 26-Mar-2024 9:00 AM EDT
Researchers a step closer to a cure for HIV
University of Bristol

In a first, the study published in the journal Emerging Microbes and Infections demonstrated the team’s patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective than other candidate HIV cure therapeutics for people living with chronic HIV on combined antiretroviral therapy (cART).

Released: 6-Mar-2024 1:05 PM EST
Children Born with HIV Surpass a Year of Remission After Pausing Treatment
Ann and Robert H. Lurie Children's Hospital of Chicago

Four children who acquired HIV in utero have remained free of detectable HIV for more than one year, according to new findings that were presented today, March 6, at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colo. The study is part of ongoing, multinational research led in part by scientists from Northwestern University Feinberg School of Medicine and Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago.

Newswise: Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy
Released: 6-Mar-2024 10:25 AM EST
Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy
Johns Hopkins Medicine

Research co-led by an investigator at Johns Hopkins Children’s Center shows that four children born with HIV who were safely removed from antiretroviral therapy (ART) continued to have undetectable levels of the virus for about a year or more without treatment. The children were among 54 newborns who were given very early treatment within the first 48 hours of life — rather than within weeks or months, as is typical. [email protected]

Released: 5-Mar-2024 5:05 PM EST
Tip Sheet: Colorectal cancer awareness resources, new initiative for rare cancers, immunotherapy for Merkel cell carcinoma — and Fred Hutch-led Cancer Screening Research Network launches
Fred Hutchinson Cancer Center

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. March is Colorectal Cancer Awareness Month, contact our media team to set up interviews.

Released: 5-Mar-2024 2:05 PM EST
UTHealth Houston research: semaglutide reduces severity of fatty liver disease in people with HIV
University of Texas Health Science Center at Houston

Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.

Released: 28-Feb-2024 2:05 PM EST
Q&A: Decline in condom use indicates need for further education, awareness
University of Washington

New research from Steven Goodreau, University of Washington professor of anthropology, shows that condom use has been trending downward among younger gay and bisexual men over the last decade, even when they aren’t taking pre-exposure prophylaxis, or PrEP.

Newswise: Wistar Scientists Discover Link Between Leaky Gut and 
Accelerated Biological Aging
Released: 23-Feb-2024 10:05 AM EST
Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging
Wistar Institute

Wistar Institute’s Dr. Mohamed Abdel-Mohsen has demonstrated a connection between viral damage to the gut and premature biological aging.

Newswise: Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
20-Feb-2024 12:05 PM EST
Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
University of California, Los Angeles (UCLA), Health Sciences

A UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and automated text messages more than doubled the use of the HIV prevention strategy, called PrEP, among younger, at-risk Americans, a group that historically has had low use of the medication.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 2:05 AM EST
Researchers are using RNA in a new approach to fight HIV
University of Waterloo

Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.

Newswise: Colonial legacies fuel unfair practices in African research
Released: 19-Feb-2024 10:05 PM EST
Colonial legacies fuel unfair practices in African research
SciDev.Net

Higher income countries must move away from unfair data practices that undermine African researchers, writes Nicki Tiffin.

   
19-Feb-2024 5:00 AM EST
Droughts may trigger HIV transmission increase among women in rural sub-Saharan Africa, study finds
University of Bristol

Droughts have the potential to increase the spread of HIV for women living in rural parts of Africa, researchers at the University of Bristol have found.

Newswise: Inequities in HIV testing, diagnosis and care for people with intellectual and developmental disabilities
Released: 15-Feb-2024 2:00 PM EST
Inequities in HIV testing, diagnosis and care for people with intellectual and developmental disabilities
Michigan Medicine - University of Michigan

There is a large discrepancy in HIV care and education for those with intellectual disabilities that results in an increase in HIV in the population.

13-Feb-2024 2:05 PM EST
Study Reveals Accelerated Aging in Women Living With HIV
Rutgers University-New Brunswick

Women with HIV experience accelerated DNA aging, a phenomenon that can lead to poor physical function, according to a study led by Stephanie Shiau, an assistant professor in the Department of Biostatistics and Epidemiology at the Rutgers School of Public Health.

Released: 13-Feb-2024 8:05 PM EST
Better diagnosis and treatment of cryptococcosis
University of Cologne

A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.

Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Newswise: New Trial Highlights Incremental Progress Towards a Cure for HIV-1
Released: 13-Feb-2024 9:00 AM EST
New Trial Highlights Incremental Progress Towards a Cure for HIV-1
University of North Carolina School of Medicine

A new clinical trial, led by clinicians and researchers at the UNC School of Medicine, show that the combination of the drug vorinostat and immunotherapy may modestly shrink the latent HIV reservoir, but more work needs to be done in the field to create a cure.

Released: 5-Feb-2024 5:05 PM EST
Virus ancestry could aid bid to predict next pandemic, study finds
University of Edinburgh

Virus family history could help scientists identify which strains have potential to become the so-called Disease X that causes the next global pandemic.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Newswise: How HIV smuggles its genetic material into the cell nucleus
Released: 25-Jan-2024 11:05 AM EST
How HIV smuggles its genetic material into the cell nucleus
Max Planck Society (Max-Planck-Gesellschaft)

Around one million individuals worldwide become infected with HIV, the virus that causes AIDS, each year.

   
Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Released: 12-Jan-2024 9:05 PM EST
Nutritional acquired immunodeficiency (N-AIDS) is the leading driver of the TB pandemic
Boston University School of Medicine

Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6 million deaths in 2021 alone. One in five incident TB cases were attributable to malnutrition, more than double the number attributed to HIV/AIDS.

Released: 11-Jan-2024 8:05 AM EST
Higher viral load during HIV infection can shape viral evolution
Oxford University Press

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.

Not for public release

This news release is embargoed until 8-Jan-2024 4:00 PM EST Released to reporters: 2-Jan-2024 9:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 4:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jan-2024 7:05 AM EST
Appalachia acutely suffers from opioid addiction and substance abuse disorders. An accredited online curriculum aids frontline prescribers in combating the crisis
The Rothman Orthopaedic Institute Foundation for Opioid Research and Education

A Philadelphia-based non-profit foundation is combating the opioid addiction epidemic at the source by educating frontline allied health professionals on various aspects of the nation's opioid crisis, specifically in Pennsylvania and the Appalachian region.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       

Not for public release

This news release is embargoed until 18-Dec-2023 5:00 PM EST Released to reporters: 12-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 18-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Engaging heterosexual men more effectively could slash HIV infections in Uganda
Released: 9-Dec-2023 10:05 AM EST
Engaging heterosexual men more effectively could slash HIV infections in Uganda
Imperial College London

A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.

Released: 7-Dec-2023 11:05 AM EST
Very Early Treatment of Newborns with HIV Could Result in Medication-Free Remission for Many Babies
Ann and Robert H. Lurie Children's Hospital of Chicago

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

Released: 5-Dec-2023 7:05 AM EST
Dose matters: HIV drug could prevent coronaviruses, study finds
University of Bristol

New research by the University of Bristol has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration. The findings could strengthen the arsenal of antiviral drugs available to combat current and future coronavirus outbreaks.

Not for public release

This news release is embargoed until 1-Dec-2023 5:05 AM EST Released to reporters: 24-Nov-2023 10:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2023 5:05 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: November Research Highlights
Released: 30-Nov-2023 11:05 AM EST
November Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
Released: 29-Nov-2023 8:00 AM EST
Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
American Thoracic Society (ATS)

The COVID-19 pandemic hampered progress in fighting tuberculosis infections worldwide. Diverted funds meant that one of the world’s leading infectious killers caused 1.3 million deaths in 2022. TB is also the leading cause of death among those with HIV /AIDS worldwide. In 2022, 167,000 people died of HIV-associated TB.

Released: 28-Nov-2023 12:05 PM EST
Ending the HIV Epidemic May Require Addressing “Everyday” Discrimination
Rutgers University-New Brunswick

Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study.

   

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2023 12:05 PM EST
World AIDS Day: How Far We’ve Come and Where We Still Need to Go
Rutgers University-New Brunswick

Jeffrey Kwong, a professor at the Rutgers School of Nursing and a national HIV expert discusses the progress made and the challenges to overcome in ending AIDS by 2030.

Released: 22-Nov-2023 9:05 AM EST
Fighting AIDS: Why the goal is to diagnose HIV before symptoms appear
Mayo Clinic

HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome), can hide in the body for many years before symptoms appear.

Released: 22-Nov-2023 9:05 AM EST
A luta contra a AIDS: por que é importante detectar o HIV antes que os sintomas apareçam
Mayo Clinic

O HIV (vírus da imunodeficiência humana) que causa a AIDS (síndrome de imunodeficiência adquirida) pode ficar oculto no corpo por muitos anos antes da manifestação dos sintomas.

Released: 22-Nov-2023 9:05 AM EST
La lucha contra el SIDA: por qué el objetivo es detectar el VIH antes de que aparezcan los síntomas
Mayo Clinic

El VIH (virus de la inmunodeficiencia humana), el virus que causa el SIDA (síndrome de inmunodeficiencia adquirida), se puede esconder en el organismo durante muchos años antes de que aparezcan los síntomas.



close
1.92046